Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Diebold Nixdorf, Incorporated (NYSE: DBD)
DBD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
25.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
10.60%
DBD Stock Analysis
DBD
PE Ratio:
27.9
DBD
PEG Ratio:
1.2
DBD
Forward EPS Growth (12 month):
23.70%
DBD
PS Ratio:
0.7
DBD
PSG Ratio:
0.2
DBD
Forward Revenue Growth (12 month):
3.20%
DBD Articles
No data was found